Westlake (WLK) Q2 2024 earnings summary

Executive summary

• Achieved record quarterly results in the Housing and Infrastructure Products (HIP) segment, driving year-over-year and sequential company-wide earnings growth, with net income reaching $313 million ($2.40 per share) and net sales of $3.2 billion, supported by improved Performance and Essential Materials (PEM) profitability.

• EBITDA rose to $744 million, up 36% quarter-over-quarter and 8% year-over-year, with HIP and PEM both contributing to margin recovery.

• HIP volume increased 15% sequentially and 16% year-over-year, while PEM volume rose 1% sequentially and 11% year-over-year, with PEM average sales price up 4% sequentially.

• Leadership transition completed with Jean-Marc Gilson appointed President and CEO, and Albert Chao named Executive Chairman.

• Announced mothballing of European epoxy units to improve profitability and ongoing anti-dumping actions in the US and EU.

Financial highlights

• Net income for Q2 2024 was $313 million, up $139 million sequentially and $16 million year-over-year, with net sales of $3.2 billion and EBITDA of $744 million.

• HIP segment delivered record EBITDA of $336 million and margin of 28%; PEM EBITDA margin improved to 19% from 13% in Q1.

• Gross profit was $664 million, up from $466 million in Q1 and $642 million in Q2 2023.

• Free cash flow for Q2 2024 was $6 million, down from $315 million in Q2 2023, impacted by higher capital expenditures.

• Cash and equivalents at June 30, 2024, totaled $3.0 billion; total debt was $4.9 billion.

Outlook and guidance

• 2024 HIP revenue expected between $4.3–$4.6 billion, with potential upside to the 22% EBITDA margin guidance.

• Cost savings of $50 million in Q2 ($85 million YTD) toward a 2024 target of $125–$150 million.

• Management remains cautiously optimistic for the remainder of 2024, monitoring weather, housing starts, and global economic indicators.

• Total capital expenditures projected at $1 billion for 2024, including a major ethylene unit turnaround in Q3.

• HIP sales expected to grow organically at a 5–7% long-term CAGR, supported by housing undersupply and infrastructure spending.